Baricitinib rapidly and sustainably relieves a patient from chronic pruritus of unknown origin refractory to dupilumab

Detalles Bibliográficos
Autores principales: Buttgereit, Thomas, Grekowitz, Eva Maria, Metz, Martin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2021
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8350330/
https://www.ncbi.nlm.nih.gov/pubmed/34401426
http://dx.doi.org/10.1016/j.jdcr.2021.06.028

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8350330/
https://www.ncbi.nlm.nih.gov/pubmed/34401426
http://dx.doi.org/10.1016/j.jdcr.2021.06.028

Ejemplares similares